The US FDA has approved a synthetic tissue substitute for the eye that will address the worldwide shortage of donors. The EverPatch from Israel’s CorNeat Vision (see here previously) is made of a polymer that stimulates the cells to accept … Continue reading →

The synthetic cornea from Israel’s CorNeat is beginning human trials, as reported here in July. This has become vital due to shortage of human corneas during Covid-19. CorNeat will soon begin trials of its EverPatch for Glaucoma surgery and is … Continue reading →